Table 2 Procedure specific data showing a significant increase of use of endoloop in phase II, concurrent with a significant increase in DO
Total | Phase I | Phase II | P-values | |
|---|---|---|---|---|
Endoloop, absolute number (relative value) | 65 (36.7%) | 7 (9.9%) | 58 (54.7%) | <0.001 |
Stapler, absolute number (relative value) | 112 (63.3%) | 64 (90.1%) | 48 (45.3%) | |
DO in min (±SD) | 61 (±24) min | 51 (±23) min | 65 (±24) min | <0.001 |
DO Endoloop in min (±SD) | 49 (±5) min | 55 (±18.6) min | 0.081 | |
DO stapler in min (±SD) | 54.5 (±24.7) min | 71 (±25.2) min | <0.001 |